| Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005) |
|---|
| 06/17/2009 | EP2069291A1 Hdac inhibitors |
| 06/17/2009 | EP2068875A2 Compositions and methods for modulating sirtuin activity |
| 06/17/2009 | EP2068857A2 Soluble epoxide hydrolase inhibitors |
| 06/17/2009 | CN100500679C Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
| 06/17/2009 | CN100500658C Pharmaceutical composition of male sexual dysfunction |
| 06/16/2009 | US7547800 Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives |
| 06/16/2009 | US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders |
| 06/16/2009 | US7547686 Combretastatin A-3 prodrug |
| 06/11/2009 | WO2009071988A1 Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide |
| 06/11/2009 | WO2009008920A3 Hydroxamic acid derivatives of 4-phenyl 4-hydroxy, 4-phenyl 4-alkoxy and 4-phenyl 4-arylalkoxy butyric acid useful as therapeutic agents for treating anthrax poisoning |
| 06/11/2009 | US20090149445 Tricyclic steroid hormone nuclear receptor modulators |
| 06/11/2009 | US20090149444 Benzylamine analogues |
| 06/11/2009 | CA2715527A1 New compounds iv |
| 06/11/2009 | CA2707248A1 New compounds ii |
| 06/10/2009 | EP2067775A1 Synthesis of UDP-glucose: N-Acylsphingosine glucosyltransferase inhibitors |
| 06/10/2009 | EP2066648A1 Substituted dimethylcyclobutyl compounds, their preparation and use in medicaments |
| 06/10/2009 | EP2066642A1 Soluble epoxide hydrolase inhibitors |
| 06/10/2009 | EP2066619A2 Soluble epoxide hydrolase inhibitors |
| 06/10/2009 | EP1858866B1 Pyroglutamate salts and their use in the optical resolution of intermediates for the synthesis of dextrocetirizine and levocetirizine |
| 06/10/2009 | EP1530470B1 Selective estrogen receptor modulators containing a phenylsulfonyl group |
| 06/10/2009 | CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/10/2009 | CN100497326C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics |
| 06/10/2009 | CN100497325C Piperazine derivatives and their use in the preparation of quinolone derivatives |
| 06/10/2009 | CN100497302C Diarylurea derivatives and their use as chloride channel blockers |
| 06/10/2009 | CN100496495C Remedies and/or preventives for diabetic ischemic heart diseases |
| 06/09/2009 | US7544835 Carboxylic acid derivative and salt thereof |
| 06/09/2009 | US7544716 N-(7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-yl)-N'-[3-piperidin-1-yl-4-(trifluoromethyl)benzyl]urea; urinary incontinence, overactive bladder, pain, nerve injury, ischemia, neurodegeneration, stroke, inflammatory disorders, asthma and chronic obstructive pulmonary disease |
| 06/09/2009 | US7544699 Aryl and heteroaryl compounds, compositions, and methods of use |
| 06/09/2009 | US7544683 Modulation of H3 receptors; obesity; trans-(4-cyclobutyl-piperazin-1-yl)-[4-(4-[1,2,4]triazol-1-yl-phenoxy)-cyclohexyl]-methanone; cis-[4-(6-chloro-pyridin-3-yloxy)-cyclohexyl]-(4-cyclobutyl-piperazin-1-yl)-methanone, |
| 06/09/2009 | CA2555035C Process for cis-1-{2-[4-(6-methoxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]ethyl}pyrrolidine |
| 06/09/2009 | CA2355720C New substituted 3-phenoxy and 3-phenylalkyloxy-2-phenyl-propylamines |
| 06/04/2009 | WO2009068595A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/04/2009 | WO2009067797A1 Cysteine protease inhibitors for the treatment of parasitic diseases |
| 06/04/2009 | WO2007113644A3 New hdac inhibitors |
| 06/04/2009 | US20090143592 Glucagon Antagonists/Inverse Agonists |
| 06/04/2009 | US20090143582 Process for making n-(diphenylmethyl)piperazines |
| 06/04/2009 | US20090143396 Sulfonyl-Substituted Aryl Compounds as Modulators of Peroxisome Proliferator Activated Receptors |
| 06/04/2009 | US20090143386 Human adam-10 inhibitors |
| 06/04/2009 | US20090143374 Use of Compounds and Compositions for the Treatment of Amyloid Diseases |
| 06/04/2009 | US20090143371 Isoxazole-pyridine derivatives |
| 06/04/2009 | US20090143369 Methods of using substituted morpholine and thiomorpholine derivatives |
| 06/04/2009 | US20090143365 Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 06/04/2009 | CA2706974A1 Novel carboxylic acid 4-phenylazo-phenyl ester derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/04/2009 | CA2706746A1 Cysteine protease inhibitors for the treatment of parasitic diseases |
| 06/03/2009 | EP2065369A1 Urea compound or salt thereof |
| 06/03/2009 | EP2064198A2 Substituted indanyl sulfonamide compounds, their preparation and use as medicaments |
| 06/03/2009 | EP2064177A2 Protease inhibitors |
| 06/03/2009 | EP1606288B1 Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain |
| 06/03/2009 | CN101448803A Novel tetralins as 5-HT6 modulators |
| 06/03/2009 | CN101448802A N-hydroxy-3-(4-{3-phenyl-S-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer |
| 06/03/2009 | CN100494187C Method for synthesizing Ranolazine |
| 06/03/2009 | CN100494186C Process for preparing N-methyl morpholine |
| 06/03/2009 | CN100494182C Regulatory factor of tumor necrosis alpha factor |
| 06/02/2009 | US7541383 Use of carboxylic acid derivatives which modulate the function and/or expression of proteins involved in atopic diseases, inflammatory conditions and cancer; treatment of asthma, allergic diseases and immunologic diseases |
| 06/02/2009 | US7541369 Amino-derivatives as novel inhibitors of histone deacetylase |
| 06/02/2009 | CA2442875C New process for the industrial synthesis of the methyl diester of 5-amino-3-carboxymethyl-4-cyano-2-thiophenecarboxylic acid, and application to the synthesis of bivalent salts ofranelic acid and their hydrates |
| 06/02/2009 | CA2394606C New modulators of dopamine neurotransmission |
| 05/29/2009 | CA2645441A1 Compositions of tolperisone |
| 05/28/2009 | WO2009065893A1 New human papilloma virus inhibitors and pharmaceutical compositions containing same |
| 05/28/2009 | WO2009065622A1 Process for making n-(diphenylmethyl)piperazines |
| 05/28/2009 | US20090137845 Novel 4-Dedimethylaminotetracycline derivatives |
| 05/28/2009 | US20090137805 N-phenyl-2-pyrimidine-amine derivatives |
| 05/28/2009 | US20090137798 Process for the Preparation of Delmopinol and Derivatives Thereof |
| 05/28/2009 | US20090137658 Benzenesulfonic acid salt compounds |
| 05/28/2009 | US20090137593 4-amino-2,6-dimethylphenol compound, process for its preparation and pharmaceutical composition comprising the same |
| 05/28/2009 | US20090137585 N-acylsulfonamide apoptosis promoters |
| 05/28/2009 | US20090137573 1,3-Disubstituted 4-methyl-1H-pyrrole-2-carboxamides and their Use in Medicaments |
| 05/28/2009 | US20090137571 2-Cyclopentyl-N-(2-bromo-6-trifluoromethyl-4-(thio)morpholin-4-yl-phenyl)-acetamide;potent openers of the KCNQ family of potassium ion channels; antiepileptic agents;anticonvulsants; anxiolytic agents; neurodegenerative disorders; analgesics for headaches, neuropathic pain; bipolar disorders |
| 05/28/2009 | US20090137570 Inhibitors of cathepsin s |
| 05/28/2009 | US20090137021 Anti-inflammatory medicaments |
| 05/28/2009 | CA2705662A1 New human papilloma virus inhibitors and pharmaceutical compositions containing same |
| 05/27/2009 | EP2062881A1 Process for making N-(diphenylmethyl)piperazines |
| 05/27/2009 | EP2061747A1 Method for producing an amine |
| 05/27/2009 | EP1694627B1 Novel ligands that are activators of the rar receptors, use in human medicine and in cosmetics |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1517900B1 Process for the production of n-(2,6-dimethyl-phenyl)-2-piperazin-1-yl-acetamide |
| 05/27/2009 | EP1222174B1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase |
| 05/27/2009 | CN101443664A Mass tags for quantitative analyses |
| 05/27/2009 | CN101440073A Aromatic chlorethazine piperazine quaternary ammonium salt derivatives, and preparation and use thereof |
| 05/27/2009 | CN101440039A Method for separating N-beta-hydroxyethyl-ethylene diamine from piperazine by-product |
| 05/27/2009 | CN100491336C Novel derivatives of 3,3-diphenylpropylamines |
| 05/26/2009 | US7538241 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 05/26/2009 | US7538224 Such as 2,4-dihydroxy-6-(2-methoxyethyl)phenylphenylketone; antitumor activity; heat shock protein (Hsp) suppression |
| 05/26/2009 | US7538216 Guanidino phenylalanin compounds used as urokinase inhibitors |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538114 Glycine transporter-1 inhibitors |
| 05/26/2009 | US7538111 N(2-hydroxyethyl)-4-methoxy-N,2,6-trimethylbenzene- sulphonamide; analgesic, antiinflammatory agent; hyperalgesia and major algesia connected with other pathological conditions such as cancer |
| 05/26/2009 | US7538101 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives |
| 05/26/2009 | CA2464223C Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2344058C Diaminopropionic acid derivatives |
| 05/26/2009 | CA2242879C Method for treating sexual dysfunctions |
| 05/21/2009 | US20090131696 Reducing Tetracycline Resistance in Living Cells |
| 05/21/2009 | US20090131452 4-[5-(3-Difluoromethoxy-benzenesulfonylamino)-2-methoxy-phenyl]- piperazine-1-carboxylic acid tert-butyl ester; nervous system disorders, particularly the central nervous system; obesity; cogition activators; Alzheimer's disease; drug abuse, drug dependence; schizophrenia; bioavailability; stability |
| 05/21/2009 | US20090131419 Which modulates activity of amyloid precursor proteins; Alzheimer's disease |
| 05/21/2009 | US20090131294 Amine reaction compounds comprising one or more active ingredient |
| 05/20/2009 | EP2060582A1 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 05/20/2009 | EP2059496A1 Acetylenic compounds |
| 05/20/2009 | CN101437800A Compounds and compositions as HEDGEHOG pathway modulators |
| 05/19/2009 | US7534886 Has improved reactivity and gives a fluorine-containing elastomer or cured product having an excellent solvent resistance, chemical resistance, releasing property, and water repellency; prepared by reacting a diester compound with an amine compound |